Relevium Technologies Inc (CVE:RLV) Director Buys C$18,000.00 in Stock

Relevium Technologies Inc (CVE:RLV) Director André Godin purchased 150,000 shares of the firm’s stock in a transaction dated Monday, October 29th. The stock was acquired at an average price of C$0.12 per share, for a total transaction of C$18,000.00.

Shares of RLV traded up C$0.01 during midday trading on Thursday, hitting C$0.11. The company’s stock had a trading volume of 155,500 shares, compared to its average volume of 744,574. Relevium Technologies Inc has a one year low of C$0.09 and a one year high of C$0.35. The company has a current ratio of 0.84, a quick ratio of 0.66 and a debt-to-equity ratio of 56.03.

ILLEGAL ACTIVITY NOTICE: “Relevium Technologies Inc (CVE:RLV) Director Buys C$18,000.00 in Stock” was originally reported by Enterprise Leader and is the sole property of of Enterprise Leader. If you are reading this story on another website, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this story can be read at

About Relevium Technologies

Relevium Technologies Inc engages in the identification, evaluation, and acquisition of assets or businesses in the health and wellness markets. It primarily focuses in the areas of e-commerce and wellness services, as well as on nutraceuticals, sports nutrition, and nutri-cosmeceutical products. The company was formerly known as BIOflex Technologies Inc and changed its name to Relevium Technologies Inc in December 2015.

Further Reading: How To Calculate Debt-to-Equity Ratio

Insider Buying and Selling by Quarter for Relevium Technologies (CVE:RLV)

Receive News & Ratings for Relevium Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relevium Technologies and related companies with's FREE daily email newsletter.

Leave a Reply